Boai NKY Pharmaceuticals Ltd (300109) — Cash Flow Reinvestment Rate
Boai NKY Pharmaceuticals Ltd (300109) has a Cash Flow Reinvestment Rate of 0.30x as of September 2025, reinvesting CN¥41.41 Million (capex CN¥41.41 Million ) from operating cash flow of CN¥139.46 Million. Check 300109 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Boai NKY Pharmaceuticals Ltd Cash Flow Reinvestment Rate (2007–2025)
Historical reinvestment intensity for Boai NKY Pharmaceuticals Ltd across 18 annual periods. Explore Boai NKY Pharmaceuticals Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Boai NKY Pharmaceuticals Ltd (2007–2025)
Year-by-year capital reinvestment analysis for Boai NKY Pharmaceuticals Ltd. For live market cap and broader valuation context, see market value of Boai NKY Pharmaceuticals Ltd.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.78x | CN¥265.14 Million | CN¥338.11 Million | CN¥220.42 Million | ▼ -42.6% |
| 2024 | 1.37x | CN¥349.68 Million | CN¥256.03 Million | CN¥274.68 Million | ▼ -27.7% |
| 2023 | 1.89x | CN¥922.52 Million | CN¥488.25 Million | CN¥377.88 Million | ▲ +70.8% |
| 2022 | 1.11x | CN¥278.44 Million | CN¥251.77 Million | CN¥266.00 Million | ▼ -89.6% |
| 2021 | 10.68x | CN¥463.85 Million | CN¥43.44 Million | CN¥228.32 Million | ▲ +2487.3% |
| 2020 | 0.41x | CN¥110.14 Million | CN¥266.87 Million | CN¥99.24 Million | ▼ -85.8% |
| 2019 | 2.91x | CN¥231.96 Million | CN¥79.64 Million | CN¥142.35 Million | ▼ -60.7% |
| 2018 | 7.41x | CN¥361.81 Million | CN¥48.81 Million | CN¥124.37 Million | ▼ -11.8% |
| 2017 | 8.40x | CN¥397.23 Million | CN¥47.28 Million | CN¥129.23 Million | ▲ +509.6% |
| 2016 | 1.38x | CN¥157.33 Million | CN¥114.14 Million | CN¥48.47 Million | ▲ +118.3% |
| 2015 | 0.63x | CN¥40.48 Million | CN¥64.12 Million | CN¥40.48 Million | ▼ -37.6% |
| 2014 | 1.01x | CN¥47.11 Million | CN¥46.60 Million | CN¥47.11 Million | ▼ -34.0% |
| 2013 | 1.53x | CN¥35.47 Million | CN¥23.17 Million | CN¥35.47 Million | ▼ -65.3% |
| 2012 | 4.41x | CN¥90.96 Million | CN¥20.65 Million | CN¥90.96 Million | ▼ -83.4% |
| 2011 | 26.46x | CN¥104.29 Million | CN¥3.94 Million | CN¥104.29 Million | ▲ +1144.2% |
| 2010 | 2.13x | CN¥21.38 Million | CN¥10.05 Million | CN¥21.38 Million | ▲ +140.5% |
| 2009 | 0.88x | CN¥25.27 Million | CN¥28.57 Million | CN¥25.27 Million | ▲ +77.3% |
| 2007 | 0.50x | CN¥4.77 Million | CN¥9.56 Million | CN¥4.77 Million | — |